Mental Health Research in Eating Disorders
NIH GUIDE, Volume 25, Number 23, July 12, 1996
PA-96-064
Keywords:
Emotional/Mental Health
0715091
Etiology
Epidemiology
Neuroscience
National Institute of Mental Health
National Institute of Dental Research
National Institute of Diabetes and Digestive and
Kidney Diseases
Office of Research on Women’s Health
PURPOSE
The National Institute of Mental Health, (NIMH), National Institute of
Dental Research (NIDR), National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), and Office of Research on Women’s Health (ORWH)
invite applications for studies relevant to the neuroscience, epidemiology,
etiology, treatment, services research, and prevention of eating disorders
(anorexia nervosa, bulimia nervosa, and binge eating disorder), and their
comorbidity with other medical, dental/craniofacial, and psychiatric disorders.
The purpose of this program announcement is to promote additional mental
health research emphasis on the broad array of influences, including gender,
on eating disorders and ingestive behaviors.
HEALTHY PEOPLE 2000
The Public Health Service (PHS) is committed to achieving the health promotion
and disease prevention objectives of "Healthy People 2000," a PHS-led national
activity for setting priority areas. This PA, "Mental Health Research in
Eating Disorders" is related to the priority area of mental health and
mental disorders. Potential applicants may obtain a copy of "Healthy People
2000" (Full report: Stock No. 017-001-00474-0 or Summary Report: Stock
No. 017-001-00473-1) through the superintendent of documents, government
Printing Office, Washington, DC 20402-9325 (telephone 202-512-1800).
ELIGIBILITY REQUIREMENTS
A variety of funding mechanisms are encouraged within this announcement,
and eligibility and requirements for these funding mechanisms vary. Applicants
are advised to contact NIMH, NIDR, or NIDDK program staff listed under
INQUIRIES for additional information and specific application procedures.
Applications may be submitted by foreign and domestic, for-profit and
non-profit organizations, public and private, such as universities, colleges,
hospitals, laboratories, units of State or local governments, and eligible
agencies of the Federal government. Foreign institutions are not eligible
for Small Grants (R03), Education projects (R25), or First Independent
Research Support and Transition (FIRST) (R29) awards. Racial/ethnic minority
individuals, women, and persons with disabilities are encouraged to apply
as principal investigators.
MECHANISM OF SUPPORT
Applications are requested under the following mechanisms: research project
grant (R01), small grant (R03), and FIRST award (R29). Applications to
NIMH are also requested under the education projects (R25) mechanism. For
additional information concerning Mental Health Education Projects, see
the NIH Guide, Vol. 25, No. 14 May 3, 1996). For research in method development,
the small grant (R03) is a particularly appropriate mechanism; investigators
may also choose to include method development as one component within research
project grant (R01) applications.
Support may be requested for a period of up to five years, except for
small grants (R03), which are limited to two years. FIRST awards must be
requested for five years. Annual noncompeting awards will be made subject
to continued availability of funds and progress achieved. Because Education
Projects, and FIRST awards have special eligibility requirements, dollar
ceilings, application formats, and review criteria, applicants are strongly
encouraged to consult with program staff (listed under INQUIRIES below)
and to obtain the appropriate additional announcements for those grant
mechanisms.
An applicant planning to submit a new (type 1) investigator-initiated
grant application requesting $500,000 or more in direct costs for any year
is advised that he or she must contact Institute program staff before submitting
the application, i.e., as plans for the study are being developed. Furthermore,
the applicant must obtain agreement fro the staff that the Institute will
accept the application for consideration for award. Finally, the applicant
must identify, in the cover letter that is sent with the application, the
staff member and Institute who agreed to accept assignment of the application.
Any application subject to this policy that does not contain the required
information in the cover letter sent with the addition information concerning
large grant applications, see the NIH GUIDE, Vol. 25, No. 14 (May 3. 1996).
RESEARCH OBJECTIVES
Summary
Mental health disorders encompassing eating disorders and ingestive behaviors
are an area of increasing public concern in the United States. Anorexia
nervosa is a syndrome characterized by body weight severely below normal,
body-image disturbance, and an intense fear of and resistance to weight
gain. Bulimia nervosa is a syndrome characterized by repeated episodes
of binge-eating followed by a variety of purging or other compensatory
behaviors such as vomiting, laxative or diuretic use, excessive exercise,
and/or fasting. Body weight, however, may remain in the normal range. Binge
eating disorder is a recently identified syndrome in which there are repeated
episodes of binge eating without subsequent regular purging behavior, typically
resulting in body weight above normal limits.
It is estimated that anorexia affects from .5 to 1 percent of teenage
and young women, and bulimia from one to three percent. women are 8 to
10 times more likely to suffer from anorexia or bulimia than en. Estimates
of binge eating disorder range from about one to four percent of the population
with women being about 1.5 times more likely to have this disorder than
men. It has been estimated, on average, that 30 percent of enrollees in
weight reduction programs suffer from binge eating disorder.
Eating disorders, which may become chronic, frequently have serious
psychological and medical consequences. Virtually all bodily systems are
affected by starvation, and cardiac, gastrointestinal, and electrolyte
disturbances are most common. Clinical depression and anxiety disorders
commonly co-occur with eating disorders. Morbidity and mortality in anorexia
nervosa are among the highest of any mental disorder. It has been estimated
that some 10 percent of patients with anorexia nervosa will die from complications
of the disorder.
Eating disorders have a high degree of comorbidity with other psychiatric
disorders, as well as with some medical disorders. In anorexia nervosa,
affective disorders are most common, followed by anxiety disorders with
obsessive compulsive disorder most prevalent. Among patients suffering
from bulimia nervosa, high rates of affective disorder and anxiety disorders
have been reported, as well as personality disorders and substance abuse.
Binge eating disorder is associated with a higher degree of psychiatric
comorbidity than is found in obese people who do not binge eat. Also, a
"failure to thrive" syndrome, characterized by malnutrition, depression,
and physical illness had been described in geriatric populations. Despite
their high degree of comorbidity, eating disorders are distinct disorders;
they do not transmute into other illnesses.
Research Scope and Goals
New research on the psychosocial and biological factors underlying eating
disorders is needed to clarify issues of etiology and treatment. While
a broad array of epidemiological, familial, biological, and treatment studies
have identified promising leads, major questions in these areas remain
unanswered.
This program announcement emphasizes the need for research on eating
disorders at all levels from fundamental studies of brain and behavior
which identify basic mechanisms, to examinations of risk factors, to epidemiological
and clinical investigations which help to successfully diagnose and treat
the disorders. The overall goal is to establish a clearer understanding
of the etiology, and treatment of these complex disorders, and ultimately,
to prevent them.
Eating Disorders research applications are welcome in the following
broad areas:
-
Neuroscience and Behavioral Science
-
Epidemiology, including Comorbidity with Other Medical and Psychiatric
Disorders and Genetic Studies
-
Behavioral Medicine
-
Treatment Studies
-
Services Research (NIMH only)
1. Neuroscience and Behavioral Science
The regulation of energy and nutrient balance involves multiple complex
systems in the brain and body. Integrative and interdisciplinary approaches
will help us understand the genetic, immune, endocrine, neural, and behavioral
determinants of energy balance, storage and body weight. Neural circuitry
and neurophysiological research in animal models of ingestion have now
advances to where the important role of genetic and other molecular factors
are rapidly being discovered. There is a pressing need to apply this knowledge
to non-human primates and humans, and for the basic research approaches
to be integrated with the development of new drugs in the clinical setting.
Research in the following areas is encouraged:
-
Individual, family and community studies to clarify the contributions of
personality, attitudes, and social dynamics to patterns of feeding, nutrition
and body weight.
-
Basic studies of biochemical, neural, and psychological mechanisms of eating
behavior, including taste and satiety.
-
The role of cognition and perception in eating behavior and eating disorders,
and their interaction with social influences on the development of the
body image.
-
Development of animal models of diagnostic or biological features of anorexia
nervosa and bulimia nervosa.
-
Animal studies of metabolic efficiency, motivation, and behavior following
changes in nutritive intake produced by peripheral, central, or environmental
manipulations.
-
The influence of sex steroid hormones on changes in feeding patterns, their
relation to gender differences in behavior and brain activity.
-
The interaction of feeding patterns with other major homeostatic systems
including reproductive-cycle, circadian rhythms, sleep and wakefulness,
and the regulation of stress.
-
The application of new molecular methods such as gene knockout technologies
to specify the role of brain peptides, hormones, and cytokines, in disordered
patterns of eating; and to identify genetic vulnerabilities and potential
pharmacological interventions for weight gain or loss.
-
Studies of peripheral autonomic function in the development and maintenance
of appetitive dysfunction or purging behaviors.
2. Epidemiology and Comorbidty
-
Research is needed to provide more accurate epidemiological data on anorexia
nervosa and bulimia nervosa. Research in the following areas is encouraged:
-
Community-based epidemiological studies to identify prevalence and incidence
of eating disorders and their comorbidity with medical (including diabetes
mellitus), psychiatric, and substance abuse disorders.
-
Prospective epidemiological studies to identify biological (including genetic),
psychological, and social factors contributing to the development and maintenance
of eating disorders and their impact on the onset and course of these illnesses
in both women and men.
-
Epidemiological study of high-risk populations, such as adolescent dieters
and athletes, and children of eating-disordered parents.
-
Studies evaluating the epidemiology, clinical course, and response to treatment
of subclasses of individuals currently identified as Eating Disorders Not
Otherwise Specified (EDNOS).
-
Longitudinal studies of the early identification of infants and children
at risk for developing eating disorders as well as follow up studies of
individuals with eating disorders to identify the long-term course and
outcome of these disorders and the impact of various types of treatment.
-
Epidemiological studies of high-risk families to examine the contribution
and relationship of genetic traits, familial dynamics, individual personalities,
and incidence of other mental disorders.
-
Studies evaluating understudied populations with eating disorders, including
men and racial and ethnic minorities.
-
Refining dental indicators for early identification and referral. (Particular
patterns of tooth erosion are, for example, characteristically seen in
bulimia, although many dental practitioners may not be aware of this).
-
Effects of malnutrition from eating disorders on dental/oral conditions
(e.g., periodontal diseases, aphthous ulcers, caries).
3. Behavioral Medicine
Little is known about the prevention of eating disorders and studies are
needed that increase understanding of the behavioral aspects of eating
disorders. Such studies include the:
-
Examination of the link between behavioral and physiological processes
underlying normal and abnormal eating.
-
Characterizations of normal and abnormal eating patterns under various
cultural and occupational conditions, and as influenced by gender-specific
attitudes and behaviors.
-
Study of comorbidity of eating disorders with physical illness.
-
Health promotion campaigns through dental offices to alert families/patients
to dental consequences.
4. Treatment Studies
Treatment studies have suggested the efficacy of specific pharmacological
and psychosocial interventions for some patients with eating disorders.
While there is general agreement that a multidimensional treatment approach,
including individual, group and/or family psychotherapy, psychopharmacotherapy,
and behavioral interventions is necessary to treat most patients with eating
disorders, few controlled clinical trials have been undertaken to evaluate
these treatment modalities. Integrated treatment studies are particularly
important to determine the efficacy of combined psychosocial and pharmacologic
therapies and the active components of each of these treatments.
Because of the serious physical health and mental health consequences
of anorexia nervosa, bulimia nervosa, and binge-eating disorder, treatments
for these disorders and intervention strategies to prevent their recurrence
need to be developed and tested. Such treatments need to be studied across
various stages of the life cycle and of the disorder. With the growing
database of efficacious short-term treatments for some eating disordered
patients, emphasis should be placed on longer-term trials aimed at maintaining
or building upon the improvement obtained during acute treatment. Treatment
studies should acknowledge the chronic nature of most eating disorders
and assess outcome accordingly, including, but not limited to, a studied
interventions success and safety in maintaining healthy eating and activity
habits, preventing relapse, and ameliorating other comorbid mental or physical
health disorders. Controlled treatment studies are needed to:
-
Assess the efficacy of psychosocial treatments for eating disorders in
a variety of treatment settings, to identify the active components of standardized
individual, group, and family/couples therapies (using, for example, manualized
cognitive-behavioral or behavioral, interpersonal, or psychodynamic approaches),
and to explore new therapeutic techniques.
-
Determine the efficacy of pharmacological treatments for eating disorders.
As with psychosocial interventions, this would include both short-term
trials and long-term continuation medication studies aimed at maintaining
or building upon the gains of acute treatment, e.g., eight restoring anorexia
nervosa.
-
Determine the effects and contributions of integrated combination treatments,
including the range of psychotherapies noted above and concurrent medication.
-
Aid in predicting and preventing relapse, long-term follow up studies to
determine which factors contribute to maintenance of improvement/remission
and to relapse or recurrence.
-
Evaluate the optimal interdigitation of treatment of eating disorders per
se with the preceding, concurrent, or subsequent treatment of comorbid
physical health or mental disorders. Examples of commonly occurring comorbidities
include the medical consequences of starvation anorexia nervosa and obesity
in binge-eating disorder.
-
Determine the mechanisms involved in abnormal weight gain or loss side
effects of commonly used treatments for major mental disorders.
-
Develop and test methods to reduce damage to teeth resulting from these
disorders.
5. Services Research (NIMH only)
Previous research suggests that while efficacious treatments exist for
some forms of eating disorders, little is known about their effectiveness--how
they work in real world settings. Furthermore, little is known about improving
the identification of affected individuals, including the development of
valid screening tool and effective programs targeting high risk populations;
access and pathways to treatment; and the cost-effectiveness of various
forms of treatment. The following are examples of research issues that
are covered under this announcement:
-
Assessment of effectiveness of proven treatments and interventions, including
long-term flow-up and measurement of multiple outcome domains.
-
Development of valid, reliable screening instruments.
-
Studies of prevention interventions targeting care-givers of the at-risk
population (i.e., teachers, coaches, parents)
-
Studies of screening and education programs to promote earlier identification
and treatment of individuals with eating disorders as well as research
on the implementation and cost-effectiveness of such programs targeting
high risk populations.
-
Studies of the cost-effectiveness of various treatments including treatment
combinations.
-
Studies of mechanisms for the effective transmission of knowledge and skills
in the provision of psychotherapeutic modalities with established efficacy
in the treatment of eating disorders to mental health practitioners and
primary care providers.
-
Long-term follow-up studies to assess maintenance and relapse prevention
strategies.
-
Assessment of treatment effectiveness in special populations, including
racial/ethnic minorities, rural populations and difference age groups,
in combination with gender-specific analysis.
INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of the NIH that women and members of minority groups and
their subpopulations must be included in all NIH supported biomedical and
behavioral research projects involving human subjects, unless a clear and
compelling rationale and justification provided that inclusion is inappropriate
with respect to the health of the subjects or the purpose of the research.
This new policy results from the NIH Revitalization Act of 1993 (Section
492B of Public Law 103-43) and supersedes and strengthens the previous
policies (Concerning the Inclusion of Women in Study Populations, and Concerning
the Inclusion of Minorities in Study Populations), which have been in effect
since 1990. The new policy contains some provisions that are substantially
different from the 1990 policies.
All investigators proposing research involving human subjects should
read the "NIH Guidelines for Inclusion of Women and Minorities as subjects
in Clinical Research," which have been published in the Federal Register
for Grants and Contracts, Volume 23, Number 11, March 18,1994.
Investigators also may obtain copies of the policy from the program
staff listed under INQUIRIES. Program staff may also provide additional
relevant information concerning the policy.
APPLICATION PROCEDURES
Applications are to be submitted on the grant application form PHS 398
(rev. 5/95) and will be accepted at the standard application deadlines
as indicated in the application kit. Application kits are available at
most institutional offices of sponsored research and may be obtained from
the Division of Research Grants, National Institutes of Health, 6701 Rockledge
Drive, Room 1040, Bethesda, MD, 20892, telephone: (301) 435-0715. The title
and number of the program announcement must be typed in Section 2 on the
face page of the original application.
Applications for the FIRST award (R29) must include at least three sealed
letters of reference attached to the face page of the original application.
FIRST award (R29) applications submitted without the required number reference
letters will be considered incomplete and will be returned without review.
The completed original application and five legible copies must be sent
or delivered to :
Division of Research Grants
National Institutes of Health
6701 Rockledge Drive, Room 1040 MSC 7710
Bethesda, MD 20892-7710
Bethesda, MD 20817 (for express/courier service)
REVIEW CONSIDERATIONS
Applications will be assigned on the basis of established PHS referral
guidelines. Applications will be reviewed for scientific and technical
merit, in accordance with the standard NIH peer review procedures. Following
scientific-technical review, the applications will receive a second level
review by the appropriate national advisory council or board.
Applications that are complete and responsive to the program announcement
will be evaluated for scientific and technical merit by an appropriate
peer review group convened in accordance with the standard NIH peer review
procedures. As part of the initial merit review, all applications will
receive a written critique and undergo a process in which only those applications
deemed to have the highest scientific merit, will be discussed, assigned
a priority score, and receive a second level review by the appropriate
national advisory council or board.
Review Criteria
-
scientific, technical, or clinical significance and originality of proposed
research;
-
appropriateness and adequacy of the experimental approach and methodology
proposed to carry out the research;
-
qualifications and research experience of the Principal Investigator and
staff, particularly, but not exclusively, in the area of the proposed research;
-
availability of the resources necessary to perform the research;
-
appropriateness of the proposed budget and duration in relation to the
proposed research;
-
adequacy of plans to include both genders and minorities and their subgroups
as appropriate for the scientific goals of the research. Plans for the
recruitment and retention of subjects will be evaluated
The initial review group will also examine the provisions for the protection
of human and anima subjects, the safety of the research environment, and
conformance with the NIH Guidelines for the Inclusion of Women and Minorities
as Subjects in Clinical Research.
AWARD CRITERIA
Applications will compete for available funds with all other approved applications.
The quality of proposed projects (as determined by peer review), the availability
of funds, and program priority will all be considered in making funding
decisions.
INQUIRIES
Inquiries are encouraged. Institute staff welcome the opportunity to clarify
any issues or questions from potential applicants.
Please direct inquiries regarding programmatic issues to:
Harold Goldstein, Ph.D
Clinical Director, Eating Disorders Program
National Institute of Mental Health
Parklawn Building, Room 10-85
Rockville, MD 20857
Telephone: (301) 443-4140
FAX: (301) 443-4045
Email: hg11p@nih.gov
Dr. Patricia S. Bryant
Behavior, Pain, Oral Function, and Epidemiology Program
National Institute of Dental Research
Building 45, Room 4AN-24K
Bethesda, MD 20892
Telephone: (301) 594-2095
FAX: (301) 480-8318
Email: BryantP@DE45.nidr.nih.gov
Susan Z. Yanovski, M.D.
Division of Digestive Disease and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases
Building 45, Room 6AN-18
Bethesda, MD 20892-6600
Telephone: (301) 594-8882
FAX: (301) 480-8300
Email: yanovskis@ep.niddk.nih.gov
Direct inquiries regarding fiscal matters to:
Diana S. Trunnell.
Grants Management Branch
National Institute of Mental Health
Parklawn Building, Room 7C-08
Rockville, MD 20857
Telephone: (301) 443-2805
FAX: (301) 443-6885
Email: Diana_Trunnell@nih.gov
Sharon Bourque
Division of Extramural Activities
National Institute of Diabetes and Digestive and Kidney Diseases
Building 45, Room 6AS-49M
Bethesda, MD 20892-6600
Telephone: (301) 594-8846
Email: bourques@ep.niddk.nih.gov
Martin Rubinstein
Division of Extramural Activities
National Institute of Dental Research
Natcher Building 45, Room 4AN-44A
Bethesda, MD 20892-6402
Telephone: (301) 594-4800
FAX: (301) 480-8301
Email: Martin.Rubinstein@nih.gov
The National Institute of Nursing Research (NINR) is not a co-sponsor of
this program announcement, but it is interested in related research on
eating disorders. For information concerning related research interests,
contact:
J. Taylor Harden, Ph.D., RN
Division of Extramural Activities
National Institute of Nursing Research
Natcher Building 45, Room 3AN-12, MSC 6300
Bethesda, MD 20892-6300
Telephone: (301) 594-5976
FAX: (301) 480-8260
Email: THarden@ep.ninr.nih.gov
AUTHORITY AND REGULATIONS
This program is described in the Catalog of Federal Domestic Assistance
Nos. 93.242 (NIMH), 93.121 (NIDR) and 93.848 (NIDDK). Awards are made under
authorization of the Public Health Service Act, Title IV, Part A (Public
Law 78-410, as amended by Public Law 99-158, 42 USC 241 and 285) and administered
under PHS grants policies and Federal Regulations 42 CFR 52 and 45 CFR
Part 74. This program is not subject to the intergovernmental review requirements
of Executive Order 12372 or Health Systems Agency review. Awards will be
administered under PHS grants policy as stated in the Public Health Service
Grants Policy Statement (April 1, 1994).
The PHS strongly encourages all grant and contract recipients to provide
a smoke-free workplace and promote the non-use of all tobacco products.
In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits
smoking in certain facilities (or in some cases, any portion of a facility)
in which regular or routing education, library, day care, health care or
early childhood development services are provided to children. This is
consistent with the PHS mission to protect and advance the physical and
mental health of the American people.
[
Return to the NIDR Home Page ] [
Return to the Program Announcements Page ]
National Institute of Dental Research
National Institutes of Health
Bethesda, MD 20892-2290